Aqua Bio Technology ASA (OSL:ABTEC)
Norway
· Delayed Price · Currency is NOK 0.9230
-0.0670 (-6.77%)
At close: Jun 18, 2025
Aqua Bio Technology ASA Revenue
In the year 2024, Aqua Bio Technology ASA had annual revenue of 107.17M NOK with 472.00% growth. Aqua Bio Technology ASA had revenue of 46.12M in the half year ending December 31, 2024, with 595.36% growth.
Revenue
107.17M
Revenue Growth
+472.00%
P/S Ratio
0.94
Revenue / Employee
2.90M
Employees
37
Market Cap
100.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107.17M | 88.44M | 472.00% |
| Dec 31, 2023 | 18.74M | 11.58M | 161.63% |
| Dec 31, 2022 | 7.16M | 5.19M | 262.49% |
| Dec 31, 2021 | 1.98M | 1.16M | 143.11% |
| Dec 31, 2020 | 812.63K | -482.56K | -37.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| Gentian Diagnostics ASA | 158.07M |
| ArcticZymes Technologies ASA | 102.97M |
| Lytix Biopharma AS | 608.00K |